Recently, JUYOU Bio-tech Co., Ltd. (referred to as “JUYOU Bio-tech”) has successfully completed its first round of financing. The funding for this round was exclusively provided by CDH Investment. The fund will primarily be used for the research and development of synthetic biology biomaterials and end products, market expansion, and capacity building.
According to public information, JUYOU Bio-tech is an innovative company specializing in the research, development, production, and sales of synthetic biological raw materials, biomedical materials, and dermatological skincare products. The company focuses on providing precise and efficient solutions for skin issues. It currently owns multiple brands, including JUYOU, DERMOCID, and Baby JUYOU.
It is reported that JUYOU Bio-tech has already achieved research and production of bioactive materials such as recombinant pearl adhesive protein, recombinant type III human collagen, recombinant fibronectin, and recombinant superoxide dismutase. These materials have been applied to several product lines of JUYOU.
Notably, JUYOU’s official flagship store on Tmall currently has 1.442 million followers. Their product “JUYOU Skin Repair Dressing” ranks first on Tmall’s list of well-reviewed moisturizing medical dressings and has maintained the top position for two weeks in a row.